Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1302-1311

  John, Malcolm D V ^b   Hibberd, Patricia L ^b   Karchmer, Adolf W ^b   Sleeper, Lynn A ^b   Calderwood, Stephen B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; NAFCILLIN; OXACILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MALE; MORTALITY; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0031811586     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516378     Document Type: Article

References (25)

1. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardiothorac Surg 1988;2:340-6.
2. Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985;72:31-7.
3. Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984;69:223-32.
4. Rutledge R, Kim BJ, Applebaum RE. Actuarial analysis of the risk of prosthetic valve endocarditis in 1,598 patients with mechanical and bioprosthetic valves. Arch Surg 1985;120:469-72.
5. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986;92:776-83.
6. Douglas JL, Cobbs CG. Prosthetic valve endocarditis. In: Kaye D, ed. Infective endocarditis. 2nd ed. New York: Raven Press, 1992:375-96.
7. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 1994;58:1073-7.
8. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardiothorac Surg 1994;8:420-4.
9. Wolff M, Witchitz S, Chastang C, Regnier B, Vachon F. Prosthetic valve endocarditis in the ICU: prognostic factors of overall survival in a series of 122 cases and consequences for treatment decisions. Chest 1995; 108:688-94.
10. Karchmer AW, Dismukes WE, Buckley MJ, Austen WG. Late prosthetic valve endocarditis: clinical features influencing therapy. Am J Med 1978;64:199-206.
11. Tornos P, Sanz E, Permanyer-Miralda G, Almirante B, Planes AM, Soler-Soler J. Late prosthetic valve endocarditis: immediate and long term prognosis. Chest 1992;101:37-41.
12. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
13. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
14. Cox DR. Regression models and life tables. Journal of the Royal Statistical Society Series B 1972;34:187-220.
15. Freeman R, Jones MR, Gould FK. Treatment of Staphylococcus aureus endocarditis: an analysis based on 25 proven cases. Eur Heart J 1986; 7:679-84.
16. Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on valvular heart disease. J Thorac Cardiovasc Surg 1994;108:207-14.
17. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med 1990;150:1305-9.
18. Masur H, Johnson WD Jr. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1980;80:31-7.
19. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110:1745-55.
20. Matsushita K, Kuriyama Y, Sawada T, et al. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve. Eur Neural 1993;33:267-74.
21. Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978;57:329-43.
22. Jones HR Jr, Sickert RG. Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges. Brain 1989;112: 1295-315.
23. Hart RG, Foster JW, Luther MF, Kanter MC. Stroke in infective endocarditis. Stroke 1990;21:695-700.
24. Hart RG, Kagan-Hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 1987;18:1048-56.
25. Gillinov AM, Shah RV, Curtis WE, et al. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996; 61:1125-30.